FdaApplication
NDA 218276
Identifiers
- fda_app_no: NDA218276
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2023-12-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FABHALTA | IPTACOPAN HYDROCHLORIDE | EQ 200MG BASE | CAPSULE;ORAL |
1 product